Parameters and indicators selection of clinical centers in predicting the patients enrollment for clinical trials

Cover Page

Cite item

Abstract

Relevance. Recruitment of patients and its compliance with the clinical trial protocol is one of the main goals of conducting a feasibility study before starting any clinical trial. Study feasibility is a must before starting any international multicentre clinical trial, and one of the main goals of feasibility is to find clinical centers with a suitable pool of patients for their subsequent selection and prediction of patient recruitment according to protocol requirements. Well-conducted fitness is clinical centers that recruit eligible patients in compliance with the protocol framework and the recruitment numbers proposed by the centers. After conducting fability, the patient recruitment prediction coincides with the protocol patient recruitment prediction. However, more than half of international multicenter clinical trials fail due to unsuccessful patient recruitment. A widely used method in the study of feasibility is a questionnaire and the reasons for subsequent failures in a clinical trial can be both an underestimation of the information provided in the questionnaires, and the lack of appropriate parameters and indicators, and, as a result, the selection of inappropriate clinical centers. Exposure to the subjectivity of opinion in the selection of sites also leads to poor selection of sites and, therefore, relevance in an objective and independent assessment remains. The aim of the study was to analyze the set of patients in selected clinical trials, identify set-related parameters and measures, and find a statistically significant relationship with a successful set of analyzed parameters and measures. Materials and Methods: A retrospective analysis of 4 international multicenter clinical trials of II-III phases was carried out for the recruitment of patients. The selection criterion is a successful recruitment of patients. Statistical analysis: descriptive statistics, multivariate analysis, correlation analysis. Results and Discussion. Parameters and indicators were found that showed a strong statistical correlation with successful recruitment of patients in clinical centers. As a result of the study, conclusions were drawn about the need to expand the use of parameters and the ratio of parameters: instead of indicators of one parameter - the expected set of patients before inclusion in the mandatory assessment of sites is a calculated parameter, it is also necessary to additionally take into account the following parameters: type of site and initial response time in days. Conclusions. Using the proposed parameters and metrics will reduce the likelihood of failure in patient recruitment. These parameters will make it possible to evaluate clinical centers with a prediction of the number of patients and to select more qualitative clinical centers.

About the authors

Svyatoslav S. Milovanov

Lomonosov Moscow State University

Author for correspondence.
Email: milovanovss@gmail.com
ORCID iD: 0000-0001-9843-6096
Moscow, Russian Federation

References

  1. Hill AB. The clinical trial. British Medical Bull. 1951;7(4):278-282, doi: 10.1093/oxfordjournals.bmb.a073919
  2. Byar DP, Simon RM, Friedewald WT, Schlesselman JJ, DeMets DL, Ellenberg JH, Gail MH, Ware JH. Randomized clinical trials. Perspectives on some recent ideas. N Engl J Med. 1976;295(2):74-80. doi: 10.1056/NEJM197607082950204
  3. Zelen M. The randomization and stratification of patients to clinical trials. J Chronic Dis. 1974;27:365-375.
  4. Friedman LM, Furberg CD, DeMets DL. Fundamentals of Clinical Trials. Springer New York, NY. 2010. 456 p. doi: 10.1007/978-1-4419-1586-3
  5. Lievre M. Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility Commentary: Early discontinuation violates Helsinki principles. BMJ. 2001;322(7286):603-606. doi: 10.1136/bmj.322.7286.603
  6. Savateev AV, Belotserkovsky M V, Moscicka K., Palumbo D. Physical assessment as a cornerstone of a successful clinical trial. Qualitative Clinical Practice. 2013;2:37-46. (In Russian).
  7. Parke J. Tips and tricks for successful participant recruitment a diversified, equitable & inclusive guide to patient recruitment. 2022, 20p. https://www.linkedin.com/feed/update/urn:li:activity:6972052 976576147456?utm_source=share&utm_medium=member_desktop (Access date 02.07. 2023).
  8. Hunninghake DB. (Workshop Chairman): Workshop on recruitment experience in NHLBI-supported clinical trials. National Heart, Lung, and Blood Institute. Bethesda, MD.1986. 486 p.
  9. Probstfield JL, Wittes JT, Hunninghake DB. Recruitment in NHLBI population-based studies and randomized clinical trials: data analysis and survey results. Control Clin Trials. 1987;8(4 Suppl):141S-149S. doi: 10.1016/0197-2456(87)90017-1
  10. Hunninghake DB, Darby CA, Probstfield JL. Recruitment experience in clinical trials: literature summary and annotated bibliography. Control Clin Trials. 1987;8(4 Suppl):6S-30S. doi: 10.1016/0197-2456(87)90004-3
  11. Guideline for good clinical practice E6(R2) EMA/CHMP/ICH/135. 1995. 68 p.
  12. Gross CP, Mallory R, Heiat A, Krumholz HM. Reporting the recruitment process in clinical trials: who are these patients and how did they get there? Ann Intern Med. 2002;137(1):10-6. doi: 10.732/0003-4819-137-1-200207020-00007
  13. Kaprin AD. Starinsky VV, Shakhzadova AO. Malignant neoplasms in Russia in 2020 (morbidity and mortality). 2021. M.: MNIOI im. P.A. Herzen. 252 p. (In Russian).
  14. Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, Ghanima W, Godeau B, González-López TJ, Grainger J, Hou M, Kruse C, McDonald V, Michel M, Newland AC, Pavord S, Rodeghiero F, Scully M, Tomiyama Y, Wong RS, Zaja F, Kuter DJ. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019;3(22):3780-3817. doi: 10.1182/bloodadvances.2019000812
  15. Bestuzhev-Lada IV. Ahead of the 21st century: prospects, forecasts, futurology. Anthology of modern classical prognostics 1959-1999. 2000. Publisher: M.: Academia. Moscow. 480 pp. (In Russian)
  16. Kibby M. Patient recruitment feasibility. Applied Clinical Trials. 2011;20(6):80-87
  17. Pirozhkova S.V. Prediction, forecast, scenario: on the issue of the diversity of the results of the study of the future. Philosophy of Science and Technology. 2016;21(2):111-129. (In Russian).
  18. Wager E, Tooley PJ, Emanuel MB, Wood SF. How to do it. Get patients’ consent to enter clinical trials. BMJ. 1995;311(7007):734-7. doi: 10.1136/bmj.311.7007.734
  19. Wynn L, Miller S, Faughnan L, Luo Z, Debenham E, Adix L, Fish B, Hustace T, Kelly T, Macdermott M, Marasciulo J, Martin B, McDuffie J, Murphy M, Rackoff B, Reed C, Seaman P, Thomas G, Wang W. Recruitment of infants with sickle cell anemia to a Phase III trial: data from the BABY HUG study. Contemp Clin Trials. 2010;31(6):558-63. doi: 10.1016/j.cct.2010.08.007
  20. Woodin KE, Schneider JC. The CRA’s Guide to Monitoring Clinical Research. Third Edition, CenterWatch. 2003. P. 447
  21. Segal JB, Powe NR. Prevalence of immune thrombocytopenia: analyses of administrative data. Journal of Thrombosis and Haemostasis. 2006;4:2377-2383. doi: 10.1111/j.1538-7836.2006.02147.x

Supplementary files

Supplementary Files
Action
1. Fig. 1. Ratio between the estimated enrollment of patients and the actual completed enrollment

Download (39KB)

Copyright (c) 2023 Milovanov S.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies